In vitro Selection and Analysis of SARS-CoV-2 Nirmatrelvir Resistance Mutations Contributing to Clinical Virus Resistance Surveillance. Severe acute respiratory syndrome coronavirus 2
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1079806
下载链接
链接失效反馈官方服务：
资源简介：
To facilitate the detection and management of potential clinical antiviral resistance, in vitro selection of drug resistant SARS-CoV-2 against the virus Mpro inhibitor nirmatrelvir (PAXLOVIDTM active component) was conducted.
创建时间：
2024-02-23
